Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Sources Sought opportunity from Department Of Health And Human Services was posted on May 21, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Upper Limb Bypass Prothesis System to include TASKA CX

Closed
75F40126SSN133891Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The U.S. Food and Drug Administration’s Office of Acquisition and Grant Services is conducting market research through a Sources Sought Notice for an upper limb bypass prosthesis system incorporating the TASKA CX or an equivalent myoelectric terminal hand. This notice, issued under solicitation number 75F40126SSN133891 and posted on May 21, 2026, with a response deadline of May 29, 2026, is not a solicitation for proposals or a contract award opportunity but is intended to gather detailed industry capabilities to inform future procurement decisions. Respondents must submit capability statements exclusively via email to Timothy Walbert at timothy.walbert@fda.hhs.gov, referencing the solicitation number in the subject line, and must avoid including any weblinks, proprietary data, or confidential information. The system must consist of a (7 1/4) inch myoelectric hand with independently articulating digits, lateral and rotational compliance, IP67 water resistance, an electronically multi-positional thumb, wrist flexion, and a quick disconnect wrist. Integration is required with a below-elbow non-amputee carbon fiber socket featuring a removable forearm shell, integrated power switch with charging port, and removable suction EMG electrodes housed in a fitted cloth sleeve—not embedded directly into the socket. All necessary cables, chargers, and batteries for operation and charging must be included, along with training for staff on use and routine maintenance, and an option to transition control from proportional EMG to pattern recognition using the same socket. Manufacturers or vendors must be certified prosthetists with prior experience in myoelectric bypass prosthesis fabrication. Respondents must provide their SAM Unique Entity Identifier, business size status under NAICS code 339113 (Surgical Appliances and Supplies Manufacturing), and if applicable, the manufacturer’s UEI and size status. Large businesses must disclose potential subcontracting opportunities for small businesses. The Buy American Act and Made in America compliance must be addressed by identifying the place of manufacturing or service performance. While no formal pricing or contract value is being solicited, informational pricing is requested for market analysis. The system must be capable of a one-year full hardware warranty from government acceptance, including full replacement at no cost for manufacturing defects or operational failures under normal use, with all shipping costs covered. Responses must demonstrate actual capability through detailed technical evidence, not general assertions.

General Info

FDA seeks sources for TASKA CX upper limb bypass prosthesis system, responses due May 29, 2026.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant SvcsView Agency

NAICS

339113 - Surgical Appliance and Supplies ManufacturingView NAICS

Place of Performance

MD, USA

Set-Aside

NONE

Documents

(1)

FDA Sources Sought Notice for Bypass Prosthesis System with TASKA CX Hand

PDFsources-sought

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Sources Sought

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
Contacts1 person available
OfficeRockville, MD, 20852, USA
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
View Agency Profile
Office AddressRockville, MD, 20852, USA

Full Description

Show more

This is a Sources Sought Notice for an upperlimb bypass prosthesis system to include a TASKA CX.  Please see attached 75F40126SSN133891.

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration, through the Center for Drug Evaluation and Research, intends to award a sole-source, firm-fixed-price purchase order to OrganoTherapeutics SARL for human iPSC-derived hindbrain organoid functional assay services. This acquisition, conducted under FAR Part 12 as a commercial service, aims to support in vitro research on drug-induced effects on respiratory-relevant neural circuits. The scope of work includes the provision of human hindbrain organoids and associated culture materials, with twelve scheduled deliveries to the FDA White Oak Campus in Silver Spring, Maryland. The first delivery will consist of 96 organoids, followed by eleven subsequent deliveries of 48 organoids each. The contractor will perform functional characterization at its own laboratory using three-dimensional multi-electrode array technology to assess electrophysiological responses to FDA-identified drug and reversal-agent combinations. Key deliverables include the raw and analyzed data, analysis files, and comprehensive study reports. The anticipated period of performance is 18 months from the date of award. Award will be based on best value, with technical capability and past performance weighted more heavily than price. All invoicing must be processed electronically through the U.S. Department of Treasury's Invoice Processing Platform.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

about 15 hours ago

DEADLINE

in 5 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS